Category: Immunoassays

Filter By
Reference: KBVH015-6
€0.00 (tax incl.)
ELISA for the qualitative determination of IgM antibodies to SARS-CoV-2 (Covid-19) whole Spike (S) protein in human serum, plasma and cell culture samples. CE marked for diagnostic use.
Reference: KBVH015-1
€0.00 (tax incl.)
ELISA for the quantitative estimation of IgG antibodies to Human Coronavirus in respiratory samples and specimens. This kit recognises all types of SARS-Cov and does not differentiate for SARS-CoV-2 or it's variants.
Reference: KBI1750
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Zolbetuximab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1749
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Ziltivekimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1748
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Zenocutuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1745
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Zanidatamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1744
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Zampilimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1742
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Zalifrelimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1741
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Zagotenemab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1740
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Xentuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1739
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Vunakizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1735
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Vopratelimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1734
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Vonlerolizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1733
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Volociximab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1732
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Volagidemab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1731
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Vofatamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1730
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Vobarilizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1728
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Vibostolimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1724
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Veltuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1721
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Varlilumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1720
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Varisacumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1718
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Vanucizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1717
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Vantictumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1713
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Utomilumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1711
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Urelumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1710
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Ulocuplumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1709
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Ublituximab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1706
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Trevogrumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1705
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tremelimumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1701
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tralokinumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1697
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Toripalimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1696
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tomuzotuximab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1695
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tomaralimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1693
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tisotumab Vedotin in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1691
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tislelizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1690
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tiragolumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1689
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tinurilimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1688
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Timolumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1687
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Timigutuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1686
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tilvestamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1684
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tilavonemab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1683
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tigatuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1682
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tidutamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1681
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tibulizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1680
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tezepelumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1676
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Teplizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1673
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Temelimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1667
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Teclistamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1665
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tarextumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1663
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tanezumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1660
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tamrintamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1658
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Talacotuzumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1657
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Tafolecimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1649
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Suvratoxumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1647
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Sutimlimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1642
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Spartalizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1636
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Sirukumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1633
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Siplizumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1626
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Setrusumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1623
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Seribantumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1620
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Semorinemab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1619
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Selicrelumab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1615
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Sasanlimab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1612
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Samrotamab in serum and plasma. Lead Time 3 - 4 weeks.
Reference: KBI1611
€0.00 (tax incl.)
Enzyme Immunoassay for the quantitative determination of Samalizumab in serum and plasma. Lead Time 3 - 4 weeks.

Menu

Settings